ArticleMedicine2026
Global burden of lung cancer attributable to secondhand smoke (1990-2021) and predictive trends to 2035.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Secondhand smoke (SHS) is closely related to lung cancer, however, the global burden of lung cancer caused by SHS remains unclear. This study used 2021 Global Burden of Disease data (GBD) to comprehensively assess the lung cancer burden associated with SHS. The number of deaths and disability-adjusted life years (DALYs) attributable to SHS was found to be 0.098 million and 2.4 million, respectively in 2021. Nevertheless, the burden of lung cancer attributable to SHS decreased from 1990 to 2019. At the sociodemographic index (SDI) district level, the middle-high SDI region had the greatest number of lung cancer deaths and DALYs attributable to SHS. Conversely, in high-SDI regions, the age-standardized mortality rateand age-standardized DALYs (age-standardized daly rate) rate of lung cancer attributable to SHS exhibit the most rapid declines. Moreover, the burden of lung cancer was mainly distributed in East Asia. The burden of lung cancer attributable to SHS is heavier for men than for women. Conversely, significant absolute and relative inequalities in lung cancer burden attributable to SHS, as measured by the SDI, were observed, with a marked decrease in these disparities over time. Globally, the number of deaths and DALYs is projected to increase, while the age-standardized rates (ASR) for both mortality and DALYs are expected to decline annually through 2035. From 1990 to 2021, an upward trend in the absolute number of lung cancer deaths and DALYs attributable to SHS was accompanied by a concurrent downward trend in their ASR. Inequalities associated with the SDI narrowed across countries over time. While this study has limitations inherent to the GBD database, these findings nonetheless underscore the importance of policies that protect nonsmokers from SHS exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.